Vandria vs Centenara Labs

Clinical-stage Swiss biotech developing small-molecule mitophagy inducers to treat age-related and chronic diseases.

Swiss aging-biotech (formerly Rejuveron) building a portfolio of therapeutics targeting the hallmarks of aging.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →